Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Hair loss linked to prostate enlargement; stress and family history important factors.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Lespedeza cuneata extract may help treat enlarged prostate.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.